Induction of CYP1A1 and ALDH-3 in lymphoid tissues from Fisher 344 rats exposed to 2,3,7,8-tetrachlorodibenzodioxin (TCDD)

Toxicology and Applied Pharmacology

Volumn 137, Issue 1, 1996, Pages 57-66

  Germolec, Dori R ^a   Henry, Ellen C ^b   Maronpot, Robert ^a   Foley, Julie F ^a   Adams, Nancy H ^c   Gasiewicz, Thomas A ^b   Luster, Michael I ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALDEHYDE DEHYDROGENASE; CYTOCHROME P450 ISOENZYME; DRUG METABOLIZING ENZYME; ETHOXYRESORUFIN DEETHYLASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; IMMUNE SYSTEM; LYMPHOID TISSUE; NONHUMAN; RAT; SPLEEN; THYMOCYTE; THYMUS;

EID: 0029965508     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0057     Document Type: Article

References (51)

1. 1-450 gene in human mitogen-stimulated lymphocytes. Cancer Res. 46, 2423-2427.
2. Birnbaum, L. S. (1994). The mechanism of dioxin toxicity: Relationship to risk assessment. Environ. Health Perspect. 102(S9), 157-167.
3. Carver, L. A., Hogenesch, J. B., and Bradfield, C. A. (1994). Tissue specific expression of the rat Ah-receptor and ARNT mRNAs. Nucleic Acids Res. 22, 3038-3044.
4. Clark, G. C., McCoy, Z., Abbott, B. N., and Lucier, G. W. (1995). Cell cycle related expression of the Ah receptor protein in human lymphocytes contrast with expression in murine lymphocytes. Submitted for publication.
5. Cook, J. C., and Hodgson, E. (1983). Induction of cytochrome P-450 by methylenedioxyphenyl compounds: Importance of the methylene carbon. Toxicol. Appl. Pharmacol. 68, 131-139.
6. Davis, D., and Safe, S. (1991). Halogenated aryl hydrocarbon-induced suppression of the in vitro plaque-forming response to sheep red blood cells is not dependent on the Ah-receptor. Immunopharmacology 21, 183-190.
7. Dooley, R. K., and Holsapple, M. P. (1988). Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin(TCDD)-induced suppression of antibody responses. Immunopharmacology 16, 167-180.
8. Dunn, T. J., Lindahl, R., and Pitot, H. C. (1988). Differential gene expression in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J. Biol. Chem. 263, 10878-10886.
9. Freedman, H. J., Parker, N. B., Marinello, A. J., Gurtoo, H. J., and Minowada, J. (1979). Induction, inhibition, and biological properties of aryl hydrocarbon hydroxylase in a stable human B-lymphocyte cell line, RPMI-1788. Cancer Res. 39, 4612-4619.
10. Gasiewicz, T. A., and Bauman, P. A. (1987). Heterogeneity of the rat hepatic Ah receptor and evidence for transformation in vitro and in vivo. J. Biol. Chem. 262, 2116-2120.
11. Germolec, D. R., Adams, N. S., and Luster, M. I. (1995). A comparative assessment of metabolic enzyme levels in macrophage subpopulations in the F344 rat. Biochem. Pharmacol. 50, 1495-1504.
12. 3H]TCDD) in human leukocytes using electrofocusing in polyacrylamide gel. Toxicol. Lett. 47, 41-51.
13. Greenlee, W. F., Dold, K. M., Irons, R. D., and Osborne, R. (1985). Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium. Toxicol. Appl. Pharmacol. 79, 112-120.
14. Hoffman, E. C., Reyes, H., Chu, F.-F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. (1991). Cloning of a factor required for the activity of the Ah (dioxin) receptor. Science 252, 954-958.
15. Holsapple, M. P., Dooley, R. K., McNerney, P. J., and McCay, J. A. (1986). Direct suppression of antibody responses by chlorinated dibenzodioxins in cultured spleen cells from (C57B1/6 × CSH)F1 and DBA/2 mice. Immunopharmacology 12, 175-186.
16. Holsapple, M. P., Morris, D. L., Wood, S. C., and Snyder, N. K. (1991). 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: Possible mechanisms. Annu. Rev. Phamacol. Toxicol. 31, 73-100.
17. Husoy, A.-M., Myers, M. S., Willis, M. L., Collier, T. K., Celander, M., and Goksoyr, A. (1994). Immunohistochemical localization of CYP1A and CYP3A-like Isozymes in Hepatic and Extrahepatic Tissues of Atlantic Cod (Gadus morhua L.), a Marine Fish. Toxicol. Appl. Pharmacol. 129, 294-308.
18. Kerkvliet, N. I., and Burleson, G. R. (1994). Immunotoxicity of TCDD and related halogenated aromatic hydrocarbons. In Immunotoxicology and Immunopharmacology (M. I. Luster, J. H. Dean, A. E. Munson, and I. Kimber, Eds.), 2nd ed., pp. 97-122. Raven Press, New York.
19. Ladies, G. S., Kawabata, T. T., Munson, A. E., and White, K. L., Jr. (1992). Metabolism of benzo[a]pyrene by murine splenic cell types. Toxicol. Appl. Pharmacol. 116, 248-257.
20. Li, W., Donat, S., Dohr, O., Unfried, K., and Abel, J. (1994). Ah Receptor in different tissues of C57B1/6J and DBA/2J Mice: Use of competitive polymerase chain reaction to measure Ah-receptor mRNA expression. Arch. Biochem. Biophys. 315, 279-284.
21. Lindahl,R. (1992). Aldehyde Dehydrogenases and their role in carcinogenesis. Crit. Rev. Biochem, Mol. Biol. 27, 283-335.
22. Lorenzen, A., and Okey, A. B. (1991). Detection and characterization of Ah receptor in tissue and cells from human tonsils. Toxicol. Appl. Pharmacol. 107, 203-214.
23. Lorr, N. A., Golemboski, K. A., Hemendinger, R. A., Dietert, R. R., and Bloom, S. E. (1992). Distribution and inducibility of a P450I activity in cellular components of the avian immune system. Arch. Toxicol. 60, 560-566.
24. Luster, M. I., Germolec, D. R., Clark, G. C., Weigand, G., and Rosenthal, G. J. (1988). Selective Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation. J. Immunol. 140, 928-935.
25. Marselos, M., and Lindahl, R. (1988). Substrate preference of a cytosolic aldehyde dehydrogenase inducible in rat liver by treatment with 3-methylcholanthrene. Toxicol. Appl. Pharmacol. 95, 339-345.
26. Marselos, M., and Vasiliou, V. (1991). Effect of various chemicals on the aldehyde dehydrogenase activity of the rat liver cytosol. Chem.-Biol. Interact. 79, 79-89.
27. Misra, R. R., Lorr, N. A., and Bloom, S. E. (1991). Cyclophosphamide metabolism in the primary immune organs of the chick: Assays of drug activation, P450 expression, and aldehyde dehydrogenase. Arch. Toxicol. 65, 32-38.
28. Narasimhan, T. R., Craig, A., Arellano, L., Harper, N., Howie, L., Menache, M., Birnbaum, L., and Safe, S. (1994). Relative sensitivities of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 and CYP1A2 gene expression and immunotoxicity in female B6C3F1 mice. Fundam. Appl. Toxicol. 23, 598-607.
29. Omiecinski, C. J., Redlich, C. A., and Costa, P. (1990). Induction and developmental expression of cytochrome P4501A1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction. Cancer Res. 50, 4315-4321.
30. Pohl, R. J., and Fouts, J. R. (1980). A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal. Biochem. 107, 150-155.
31. Poland, A., and Knutson, J. C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22, 517-554.
32. b-3 alleles. Mol. Pharmacol. 38, 306-312.
33. Russo, J. E. and Hilton, J. (1988). Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant 1210 cells. Cancer Res. 48, 2963-2968.
34. Sahovic, E. A., Colvin, M., Hilton, J., and Ogawa, M. (1988). Role for aldehyde dehydrogenase in survival of progenitors for murine blast cell colonies after treatment with 4-hydroperoxy-cyclophosphamide in vitro. Cancer Res. 48, 1223-1226.
35. Shand, F. L. (1978). The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro. Immunology 35, 1017-1025.
36. Smialowicz, R. J., Riddle, M. M., Williams, W. C., and Diliberto, J. J. (1994). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: Differences between mice and rats. Toxicol. Appl. Pharmacol. 124, 248-256.
37. Soon, B.-J., Gelboin, H. V., Park, S. S., Tsokos, G. C., and Friedman, F. K. (1985). Monoclonal antibody-directed radioimmunoassay detects cytochrome P-450 in human placenta and lymphocytes. Science 228, 490-492.
38. Steppan, L. B., DeKrey, G. K., Fowles, J. R., and Kerkvliet, N. I. (1993). Polychlorinated biphenyl (PCB) induced alterations in the cytokine profile in the peritoneal cavity of mice during the course of P815 tumor rejection. J. Immunol. 150, 134. [Abstract]
39. Suolinna, E. M., Vanttinen, E., and Aitio, A. (1982). Induction of aryl hydrocarbon hydroxylase activity in cultured human lymphocytes. Toxicology 24, 73-84.
40. Takimoto, K., Lindahl, R., and Pitot, H. C. (1991). Superinduction of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of aldehyde dehydrogenase by the inhibition of protein synthesis. Biochem. Biophys. Res. Comm. 180, 953-959.
41. Talalay, P., de Long, M. J., and Prochaska, H. J. (1988). Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. USA 85, 8261-8265.
42. Taylor, M. J., Lucier, G. W., Mahler, J. F., Thompson, M., Lockhart, A. C., and Clark, G. C. (1992). Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol. Appl Pharmacol. 117, 126-132.
43. Tomar, R. S., and Kerkvliet, N. I. (1991). T helper cell function in mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Lett. 57, 55-64.
44. Vanden Heuvel, J. P., Clark, G. C., Thompson, C. L., McCoy, Z., Miller, C. R., Lucier, G. W., and Bell, D. A. (1993). CYP1A1 mRNA levels as a human exposure biomarker: Use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carcinogenesis 14, 2003-2006.
45. Vasiliou, V., Athanasiou, K., and Marselos, M. (1988). The use of ALDH induction as a carcinogenic risk marker in comparison with a typical in vitro mutagenicity system. In Pro Advanced Research Workshop on the ''Biologically Based Methods for Cancer Risk Assessment (C. C. Travis, Ed), pp. 231-240. Plenum, New York and London.
46. Vos, J. G., and Luster, M. I. (1989). Immune alterations. In Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related Products (R. Kimbrough and A. Jensen, Eds.), pp. 295-322. Elsevier Science, New York.
47. Waithe, W. I., Michaud, M., Harper, P. A., Okey, A. B., and Anderson, A. (1991). The Ah receptor, cytochrome P450IA1 mRNA induction, and aryl hydrocarbon hydroxylase in a human lymphoblastoid cell line. Biochem. Pharmacol. 41, 85-92.
48. Whitlock, J. P. (1990). Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu. Rev. Pharmacol. Toxicol. 30, 251-277.
49. Whitlock, J. P., Jr., Cooper, H. L., and Gelboin, H. V. (1972). Aryl hydrocarbon (benzopyrene) hydroxylase is stimulated in human lymphocytes by mitogens and benz[a]anthracene. Science 177, 618-619.
50. Wood, S. C., Jeong, H. G., Morris, D. L., and Holsapple, M. P. (1993). Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsilar lymphocytes. Toxicology 81, 131-143.
51. Yang, K. H., Kim, B. S., Munson, A. E., and Holsapple, M. P. (1986). Immunosuppression induced by chemicals requiring metabolic activation in mixed cultures of rat hepatocytes and murine splenocytes. Toxicol. Appl. Pharmacol. 83, 420-429.